abstract |
A method of treating a subject suffering from treatment resistant depression (TRD) is disclosed. The method incorporates the measure of biomarkers of neuroinflammation, such as hsCRP, white matter free water, and others, followed by administration of a selective antisolTNF therapy in such a patient with TRD and neuroinflammation. |